Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
111 Cards in this Set
- Front
- Back
Benzodiazepines
|
1. Alprazolam (Xanax)
2. Chlordiazepoxide (Librium) 3. Diazepam (Valium) 4. Lorazepam (Ativan) 5. Midazolam (Versed) 6. Ozazepam (Serax) 7. Temazepam (Restoril) 8. Triazolam (Halcion) |
|
Benzodiazepine Antagonist
|
Flumazenil (Romazicon)
|
|
Barbiturates
|
1. Butalbital (Fiorinal)
2. Pentobarbital (Nembutal) 3. Phenobarbital 4. Thiopental (Pentothal) |
|
Centrally Acting Muscle Relaxants
|
1. Baclofen (Lioresal)
2. Cyclobenzaprine (Flexeril) 3. Diazepam (Valium) 4. Metaxalone (Skelaxin) 5. Tizanidine (Zanaflex) |
|
Miscellaneous Anxiolytics and Sedative Hypnotics
|
1. Alcohol
2. Buspirone (Buspar) 3. Eszopiclone (Lunesta) 4. Gammahydroxybutyrate (GHB) 5. Melatonin 6. Ramelteon (Rozerem) 7. Zolpidem (Ambien) 8. Zaleplon (Sonata) |
|
Drugs for Treatment of Alcoholism
|
1. Disulfiram (Antibuse)
2. Acamprosate (Campral) 3. Naltrexone (ReVIA) |
|
Therapeutic Effects of Benzodiazepines
|
1. Anxiolytic effect
2. Sedative-hypnotic effect 3. Anticonvulsant effect 4. Muscle relaxation |
|
Mechanism of Action of Benzodiazepines and Barbiturates
|
*enhance the effects of the inhibitory neurotransmitter GABA
*interaction of GABA with its receptor causes the chloride channel to open *influx of chloride which decreases neuronal firing |
|
ADRs of Benzodiazepines
|
1. Sedation, drowsiness
2. mental clouding, confusion, slurred speech 3. memory impairment (anterograde amnesia 4. Disinhibition of suppressed behavior 5. possible teratogenicity |
|
CNS ADRs of Benzodiazepines
|
1. Euphoria
2. Hangover 3. Rebound anxiety 4. Respiratory depression 5. Toerance 6. Dependence |
|
Withdrawal syndrome of benzodiazepines
|
agitation, anxiety, irritability, insomnia, abdominal cramps, sweating, seizures
|
|
Effects of Benzodiazepines of Sleep
|
1. Decreased Sleep latency (time needed to fall asleep)
2. Some decrease in duration of REM sleep 3. REM Rebound = increase in REM sleep which leads to increased frequency and intensity of bizarre or frightening dreams |
|
Effects of Alcohol and Barbiturates on sleep
|
Very poor quality of sleep = decrease in duration of REM sleep
|
|
Lorazepam
|
Benzodiazepine not oxidized in the liver and only goes through phase 2 metabolism
|
|
Diazepam and Chlordiazepoxide
|
Benzodiazepines oxidized in the liver to form active metabolites that tend to have longer durations of action
|
|
Uses of Benzodiazepines
|
1. treatment of Anxiety
2. sedative-hypnotic agents 3. treatment of acute alcohol withdrawal 4. treatment of convulsive seizures and status epilepticus 5. relief of skeletal muscle spasm and spasticity 6. preanesthetic medication and as an anesthetic supplement 7. induction of anesthesia |
|
Major Drug Interactions with Benzodiazepines
|
1. Alcohol and CNS depressants
2. Cimetidine 3. Disulfiram 4. Isoniazid 5. Digoxin |
|
Short Acting Benzos
|
1. Midazolam
2. Triazolam |
|
Intermediate Acting Benzos
|
1. Temazepam
2. Oxazepam 3. Lorazepam 4. Alprazolam |
|
Long Acting Benzos
|
1. Chlordiazepoxide
2. Diazepam |
|
Long Acting Barbiturates = anticonvulsants
|
1. Phenobarbital
|
|
Intermediate/Short Acting Barbiturates = sedative/hypnotics
|
1. Pentobarbital
2. Butalbital |
|
Ultra Short Acting = induction of anesthesia
|
1. Thiopental
|
|
Have some ability to cause opening of the Chloride channels without GABA
|
Barbiturates
|
|
Pharmacokinetics of Barbiturates
|
1. redistribution is important for the termination of action
2. induction of microsomal enzymes = drug interactions |
|
ADRs of Barbiturates
|
1. sedation, drowsiness, confusion
2. hangover effect 3. respiratory depression 4. nausea/GI upset 5. aggravation of acute intermittent porphyria |
|
Drug Interactions with Barbiturates
|
1. CNS depressants
2. MAO inhibitors 3. Warfarin |
|
Uses of Barbiturates
|
1. sedative/hypnotics and anxiolytics
2. induction of surgical anesthesia 3. induction of coma after head injuries 4. anticonvulsants 5. adjuncts for treatment of tension headache |
|
Signs of Barbiturate Withdrawal
|
insomnia, anxiety, restlessness, irritability, tremors, EEG changes
|
|
Barbiturate Poisoning
|
severe CNS depression (coma and depressed respiration) can lead to hypotension, shock, and circulatory collapse
|
|
Treatment of Barbiturate Poisoning
|
No specific antidotes so it is symptomatic (ventilation and hydration)
|
|
Buspirone (Buspar)
|
alleviates mild-moderate anxiety with minimal sedative-hypnotic, muscle relaxant, or respiratory depressant effects
|
|
Drug of choice for treatment of anxiety in patient with a history of alcohol or sedative abuse
|
Buspirone (Buspar)
|
|
Side effects of Buspirone (Buspar)
|
dizziness, headache, irritability, tachycardia but are relatively safe
|
|
Mechanism of action of Zolpidem (Ambien), Zaleplon (Sonata), and Eszopiclone (Lunesta)
|
NOT A BENZO, but acts at BENZO receptor
enhance the effects of GABA at the benzodiazepine receptor-chloride channel complex by interacting with a subtype |
|
Lowest Tendency of decreasing REM sleep
|
Zolpidem (Ambien), Zaleplon (Sonata), and Eszopiclone (Lunesta)
|
|
Duration of action of Zolpidem and Eszopiclone
|
6-8 hours
|
|
Duration of Action of Zaleplon
|
2-4 hours
|
|
Side effects of Zolpidem, Zaleplon, Eszopiclone
|
*PERFORMING COMPLEX BEHAVIORS WHILE SLEEPING*
sedation, amnesia, impaired cognitive and motor function |
|
Gammahydroxybutyrate (GHB)
|
analog of GABA that can cross the BBB
|
|
Medication that has been abused by athletes
|
Gammahydroxybutyrate (GHB)
|
|
Antihistamines used as mild sedatives
|
1. Hydroxyzine (Atarax, Vistaril)
2. Promethazine (Phenergan) |
|
Antihistamine used in over the counter sleep aids
|
1. diphenhydramine
|
|
Melatonin and Ramelteon (Rozerem)
|
used for sleep aid that help regulate circadium rhythm and have little potential for abuse or dependence
|
|
Beta Blockers used for use of anxiety
|
Propranolol = situational anxiety(stage fright)
|
|
Flumazenil (Romazicon)
|
Benzodiazepine antagonist used to reverse the CNS depressant effects of Benzos
|
|
ADRs of Flumazenil (Romazicon)
|
1. can trigger seizures
2. can precipitate symptoms of withdrawal |
|
Use of Diazepam (Valium)
|
treating spasticity and muscle spasms
|
|
Baclofen (Lioresal)
|
analog of GABA that acts as an agonist at certain types of GABA receptors (GABAb)
|
|
Uses of Baclofen (Lioresal)
|
treat spasticity from multiple sclerosis, spinal cord injuries, etc
|
|
ADRs of Baclofen (Lioresal)
|
1. CNS depression = sedation, drowsiness, ataxia
2. euphoria 3. hallucinations 4. tremors 5. seizures |
|
Cyclobenzaprene (Flexeril) and Metaxalone (Skelaxin)
|
structurally related to the tricyclic antidepressant that inhibits both gamma and alpha motor systems
|
|
uses of cyclobenzaprene (Flexeril) and Metaxalone (Skelaxin)
|
treat muscle spasms of local origin (strains, pulls)
|
|
ADRs of cyclobenzaprene (Flexeril) and Metaxalone (Skelaxin)
|
CNS depression (sedation, drowsiness) and anticholinergic effects
|
|
Absorption of alcohol (ethanol)
|
passive diffusion from the stomach and small intestine
|
|
where is alcohol distributed to in the body
|
body water
|
|
2 forms of alcohol metabolism
|
1. Alcohol Dehydrogenase Pathway
2. Microsomal Ethanol Oxidizing System |
|
Alcohol oxidation occurs where? Alcohol oxidation follows what kinetics?
|
1. liver
2. zero order kinetics |
|
the average adult can metabolize how much alcohol?
|
1 drink per hour
|
|
Main course of alcohol metabolism at lower doses of alcohol
|
alcohol dehydrogenase pathway
|
|
at higher doses and with chronic consumption what is the main course of alcohol metabolism
|
Microsomal ethanol oxidizing system
|
|
Disulfiram (Antabuse)
|
inhibitor of aldehyde dehydrogenase that blocks the conversion of acetaldehyde to acetate
|
|
Signs that patient on Disulfiram (Antabuse) has consumed alcohol
|
flushing, headache, nausea, and confusion
|
|
Important side effect with Disulfiram (Antabuse) and Naltrexone (ReVia)
|
hepatotoxicity
|
|
Effects of alcohol on the CNS
|
1. first - stimulator = confident, social, outgoing
2. impairs intellectual and motor function 3. anterograde amnesia |
|
Effects of alcohol on sleep
|
Reduces sleep latency, reduces amount of time spent in REM sleep, and decreases overall quality of sleep
|
|
Possible alcohol biomarker used to see if alcohol is still in system up to 4-5 days later
|
Alcohol Glucuronide
|
|
Mechanism of Action of alcohol in the CNS
|
enhanced effects of GABA at the GABA receptor-chloride channel complex
|
|
Cardiovascular effects of alcohol
|
1. cutaneous vasodilation - warm flushing and feel warm
2. severe intoxication - cardiomyopathy, arrythmias, HTN |
|
Other actions of Alcohol
|
1. inhibits secretion of ADH
2. stimulates gastric acid secretion 3. can increase HDL and lower LDL 4. small amounts - suppress appetite |
|
Effects of alcohol on the liver
|
1. induces microsomal drug metabolizing system
2. accumulation of fat 3. inflammation, scarring, cirrhosis |
|
Characterizations of fetal alcohol syndrome
|
1. microcephaly
2. mental retardation 3. poor coordination 4. flattened face |
|
Alcohol Withdrawal Syndrome
|
1. 6-24 hours after alcohol is stopped and resolves within 5 days
2. mild = anxiety, irritability, insomnia, nausea, sweating 3. severe = anxiety, fear, hallucinations, delirium, tremors *Can be serious, or life threatening |
|
Management of Alcohol Withdrawal Syndrome
|
1. prevent seizures, delirium, arrhythmias
2. Benzos suppress symptoms (lorazepam, oxazepam) 3. phenytoin for seizures |
|
Use of Clonidine in alcohol withdrawal syndrome
|
alleviate some of the autonomic effects
|
|
Naltrexone (ReVia)
|
long-acting opioid antagonist that reduces the craving for alcohol
|
|
Acamprosate (Campral)
|
newer drug approved to decrease craving for alcohol and to help maintain abstinence in recovering alcoholics
|
|
main side effects of Acamprosate (Campral)
|
diarrhea, anxiety, insomnia, depression
*less potential for hepatotoxicity* |
|
Phenothiazines
|
1. Chlorpromazine (Thorazine)
2. Fluphenazine (Prolixin) 3. Prochlorperazine (Compazine) 4. Trifluorperazine (Stelazine, Suprazine) |
|
Nonphenothiazines (Butyrophenones)
|
Haloperidol (Haldol)
|
|
Second Generation or Atypical Antipsychotics
|
1. Clozapine (Clozaril)
2. Olanzapine (Zyprexa) 3. Risperidone (Risperdal) 4. Aripiprazole (Abilify) 5. Quetiapine (Seroquel) 6. Ziprasidone (Geodon) |
|
Antipsychotic effects
|
1. alleviate psychotic symptoms
2. effects develop slowly over 2-4 weeks 3. usually no tolerance 4. usually unpleasant |
|
Sedation of effects of Antipsychotics
|
1. occurs early in therapy
2. tolerance after a few weeks |
|
Pharmacological effects of Antipsychotics
|
1. Antipsychotic
2. Sedation 3. Lower seizure threshold 4. Antiemetic 5. Anticholinergic 6. Cardiovascular 7. Weight gain 8. Inhibit ejactulation, Calcium process |
|
greater effect against "positive" symptoms of schizophrenia
|
Chlorpromazine and other "first generations"
|
|
Antiemetic used to desensitize CTZ and controls nausea and vomiting
|
prochlorperazine (Compazine)
|
|
Cardiovascular effects of Antipsychotics
|
1. orthostatic hypotension
2. tachycardia 3. EKG changes 4. cardiac arrest and sudden death (older drugs have Black Box Warning) |
|
Toxic effects of Antipsychotics
|
1. Idiosyncratic and allergic reactions
2. Neurological Side effects |
|
Neurological Side effects with Antipsychotics (EPS)
|
1. Acute dystonia
2. Akathisia 3. Parkinsonism 4. Neuroleptic Malignant Syndrome(NMS) 5. Tardive dyskinesia |
|
Acute dystonia
|
1. bizarre muscle spasms, facial grimacing, twitching
2. onset is early 3. Remove drug or add anticholinergic |
|
Akathisia
|
1. need to be in motion, fidgeting, packing
2. onset is early 3. remove drug, add anticholinergic or propranolol/benzo |
|
Parkinsonism
|
1. tremor and muscular rigidity
2. onset is early 3. remove drug or add anticholinergic |
|
Neuroleptic Malignant Syndrome (NMS)
|
1. stupor, severe rigidity, hyperthermia - can be fatal
2. early in therapy and can persist for weeks 3. use Dantrolene or bromocryptine |
|
Dantrolene (Dantrium)
|
*Treats Neuroleptic Malignant Syndrome*
inhibits the release of Calcium from the sarcoplasmic reticulum |
|
Bromocryptine (Parlodel)
|
*Treats Neuroleptic Malignant Syndrome*
a dopamine agonist |
|
Tardive dyskinesia
|
1. involuntary movements - sucking of lips, jaw movements, protrusion of tongue
2. develops after long term therapy 3. more common in females and elderly 4. No treatment |
|
Mechanism of Action of antipsychotics
|
1. some are antagonists at D2 receptors
2. some are antagonists at the 5HT receptors 3. some do a little of both |
|
Trifluorperazine (Stelazine)
|
*Piperazine Phenothiazine*
1. more potent than chlorpromazine 2. less sedation and anticholinergic 3. more EPS |
|
Fluphenazine
|
*Piperazine Phenothiazine*
1. long acting form can be given by depot injection every 3-4 weeks 2. high EPS |
|
Prochlorperazine
|
*Piperazine Phenothiazine*
1. antipsychotic used as an antiemetic |
|
Haloperidol
|
*Butyrophenone*
1. less anticholinergic activity 2. more EPS 3. less sedation 4. long acting form as injection |
|
Clozapine
|
*2nd Generation*
1. block mesolimbic DA receptors and also 5HT2 receptors 2. strong anticholinergic activity and FEW EPS 3. useful in patients who don't respond to other drugs |
|
Black Box Warning for Clozapine
|
Potential to cause granulocytopenia and agranulocytosis
|
|
Common side effects of all 2nd generation antipsychotics
|
1. weight gain
2. hyperglycemia 3. type 2 diabetes |
|
Olanzapine
|
*2nd Generation*
1. may cause EPS 2. approved for treatment of schizophrenia and mania |
|
Risperidone
|
*2nd Generation*
1. blocks DA and 5HT receptors 2. less EPS than older drugs but more than clozapine and olanzapine 3. most widely used |
|
Quetiapine & Ziprasidone
|
*2nd Generation*
1. effective against both positive and negative symptoms 2. very low chance of EPS 3. fairly expensive and less efficacious |
|
2nd generation antipsychotic that has fewer metabolic complications
|
Ziprasidone
|
|
Clinical Uses of Antipsychotics
|
1. Psychosis - schizophrenia
2. Other psychoses (severe acute mania, bipolar) 3. Tic Disorders 4. Antiemetic 5. Intractable hiccup |
|
Higher potency drugs (trifluoperazine, fluphenazine, haloperidol)
|
produce fewer cardiovascular and anticholinergic side effects but more EPS
|
|
Lower Potency drugs
|
produce more cardiovascular and anticholinergic side effects but less EPS
|